JP2004529145A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529145A5
JP2004529145A5 JP2002581402A JP2002581402A JP2004529145A5 JP 2004529145 A5 JP2004529145 A5 JP 2004529145A5 JP 2002581402 A JP2002581402 A JP 2002581402A JP 2002581402 A JP2002581402 A JP 2002581402A JP 2004529145 A5 JP2004529145 A5 JP 2004529145A5
Authority
JP
Japan
Prior art keywords
compound
formula
ring
compound according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002581402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529145A (ja
Filing date
Publication date
Priority claimed from GBGB0109122.2A external-priority patent/GB0109122D0/en
Application filed filed Critical
Publication of JP2004529145A publication Critical patent/JP2004529145A/ja
Publication of JP2004529145A5 publication Critical patent/JP2004529145A5/ja
Withdrawn legal-status Critical Current

Links

JP2002581402A 2001-04-11 2002-04-11 新規化合物 Withdrawn JP2004529145A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0109122.2A GB0109122D0 (en) 2001-04-11 2001-04-11 Novel compounds
PCT/EP2002/004069 WO2002083645A1 (en) 2001-04-11 2002-04-11 Novel compounds

Publications (2)

Publication Number Publication Date
JP2004529145A JP2004529145A (ja) 2004-09-24
JP2004529145A5 true JP2004529145A5 (enExample) 2005-12-22

Family

ID=9912713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002581402A Withdrawn JP2004529145A (ja) 2001-04-11 2002-04-11 新規化合物

Country Status (7)

Country Link
US (2) US20040152730A1 (enExample)
EP (1) EP1377555B1 (enExample)
JP (1) JP2004529145A (enExample)
AT (1) ATE352543T1 (enExample)
DE (1) DE60217843D1 (enExample)
GB (1) GB0109122D0 (enExample)
WO (1) WO2002083645A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0303086D0 (en) 2003-02-11 2003-03-19 Merck Sharp & Dohme New compounds
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
US20050241110A1 (en) * 2004-04-09 2005-11-03 Bruce Baker Ergonomic handles, especially for garden tools
US20090227799A1 (en) * 2004-08-09 2009-09-10 Kazutaka Nakamoto Novel Antimalarial Agent Containing Heterocyclic Compound
GB0419192D0 (en) 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
ATE398616T1 (de) * 2005-02-04 2008-07-15 Ctg Pharma S R L Neue 4-aminochinolinderivate als antimalariamittel
WO2006106711A1 (ja) 2005-03-30 2006-10-12 Eisai R & D Management Co., Ltd. ピリジン誘導体を含有する抗真菌剤
GB0509405D0 (en) * 2005-05-10 2005-06-15 Merck Sharp & Dohme Therapeutic compounds
GB0515580D0 (en) 2005-07-29 2005-09-07 Merck Sharp & Dohme Therapeutic compounds
JP2009504642A (ja) * 2005-08-11 2009-02-05 アストラゼネカ・アクチエボラーグ Nk−3受容体の調節剤としてのオキソピリジルキノリンアミド
WO2007018465A1 (en) * 2005-08-11 2007-02-15 Astrazeneca Ab Amide alkyl pyridiyl quinolines as nk3 receptor modulators
AR057130A1 (es) 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
WO2008035726A1 (en) * 2006-09-21 2008-03-27 Eisai R & D Management Co., Ltd. Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
TW200841879A (en) * 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
EP2143723A4 (en) * 2007-04-27 2011-05-18 Eisai R&D Man Co Ltd SALT OF A PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROCYCLE OR CRYSTALS OF THE SAME
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8466290B2 (en) 2008-07-10 2013-06-18 Pharma Ip General Incorporated Association STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
US8188119B2 (en) * 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
AU2009315761A1 (en) 2008-11-14 2010-05-20 F. Hoffmann-La Roche Ag Quinazoline derivatives as NK3 receptor antagonists
JP2022527279A (ja) * 2019-03-28 2022-06-01 エピザイム,インコーポレイティド キノリン誘導体及び癌の治療のためのその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270615B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Uso di derivati di chinolina
AR004735A1 (es) * 1995-11-24 1999-03-10 Smithkline Beecham Spa Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento.
IL133036A0 (en) * 1997-05-23 2001-03-19 Smithkline Beecham Spa Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
WO2000031037A1 (en) * 1998-11-20 2000-06-02 Smithkline Beecham S.P.A. Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
GB9825554D0 (en) * 1998-11-20 1999-01-13 Smithkline Beecham Spa Novel Compounds

Similar Documents

Publication Publication Date Title
JP2004529145A5 (enExample)
RU2328494C2 (ru) Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло[2.2.1]гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
ES2617619T3 (es) Combinaciones de fármacos que comprenden un inhibidor de DGAT y un agonista de PPAR
RU2312106C2 (ru) Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar
RU2007120454A (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
RU2394028C2 (ru) Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы
JP2005509622A5 (enExample)
JP2007517846A5 (enExample)
JP2010539110A5 (enExample)
HUT77372A (hu) Új benzil-pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
JP2005505618A5 (enExample)
CA2401502A1 (en) Carboxylic acid derivatives as ip antagonists
JP2020500182A5 (enExample)
JP2005502621A5 (enExample)
JP2004525183A5 (enExample)
RU2009139915A (ru) Производные имидазолидинона
JPH07501313A (ja) キノロン誘導体
RU2007108863A (ru) Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3
JP2012510957A5 (enExample)
RU2006130000A (ru) Органические соединения
RU2460723C2 (ru) Производные 4-(1-аминоэтил)циклогексиламина
RU2008119460A (ru) Производные карбамоилбензола в качестве ингибиторов липаз и фосфолипаз
TW200619195A (en) Phenylpyrrolidine dopamine D3 receptor antagonists
RU2010154417A (ru) Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств